Trimi: The Only Provider with All 3 GLP-1 Medications

Most telehealth weight loss providers offer one or two GLP-1 medications. Trimi is different. We are the only provider offering all three generations of incretin-based weight loss therapy: compounded semaglutide ($99/month), compounded tirzepatide ($125/month), and compounded retatrutide. This gives our physicians -- and our patients -- the flexibility to find the right medication for every situation.

Three Generations of GLP-1 Therapy

The evolution of GLP-1 medications has been rapid and transformative. Each generation builds on the previous one, adding receptor targets and delivering more weight loss. Understanding these differences helps explain why access to all three matters.

Why Having All Three Matters

1. Every Patient Is Different

Clinical trials report averages, but individual responses vary dramatically. Some patients lose 25% of body weight on semaglutide alone. Others lose only 8-10% on the same medication. Genetic factors, baseline metabolism, gut microbiome composition, and other variables influence how each person responds to a specific GLP-1 receptor agonist.

When your provider has access to all three medications, they can start with the most evidence-backed, affordable option (semaglutide at $99/month) and adjust based on your actual response -- not just guess and hope.

2. Seamless Switching When Needed

Approximately 15-20% of patients on any GLP-1 medication will need to switch due to inadequate response, intolerable side effects, or plateau after initial success. With most providers, switching means finding a new provider, repeating medical intake, and starting from scratch. At Trimi, your physician can transition you to a different medication within the same program -- your medical history, lab results, and treatment context carry over seamlessly.

3. Step Therapy That Actually Works

The most effective approach to GLP-1 therapy often follows a step pattern. Start with semaglutide to establish GLP-1 tolerance and achieve initial weight loss. If results plateau or more weight loss is needed, step up to tirzepatide for the dual GIP/GLP-1 mechanism. For patients with significant remaining weight to lose or concurrent conditions like MASH, retatrutide offers the most potent option available.

This step approach only works when the same provider can offer all three rungs of the ladder.

4. Side Effect Optimization

While all three medications share similar GI side effects, individual tolerance varies. Some patients tolerate tirzepatide better than semaglutide despite its higher potency. Others do best on the more established semaglutide protocol. Having all three options means your provider can optimize for the best efficacy-to-side-effect ratio for your specific biology.

The Trimi Cost Advantage

All Trimi programs include the medication, licensed physician oversight, ongoing medical support, dose adjustments, free shipping, and injection supplies. No hidden fees. No insurance required. Cancel anytime.

How Trimi Physicians Choose Your Medication

Your Trimi physician considers multiple factors when recommending a medication: body mass index and weight loss goals, previous experience with GLP-1 medications, medical history and comorbidities (diabetes, liver disease, cardiovascular risk), side effect sensitivity, budget considerations, and timeline expectations.

Quality and Safety Standards

All Trimi medications are sourced from FDA-registered 503B compounding pharmacies using USP-grade ingredients. Every batch undergoes third-party testing for potency, sterility, and endotoxin levels. Our physicians are licensed and experienced in GLP-1 prescribing. We maintain full medical records and require appropriate lab monitoring.

Getting Started with Trimi

Starting treatment takes just a few steps. Complete our brief online health assessment (5 minutes), consult with a licensed Trimi physician, receive your personalized medication recommendation, get your medication shipped directly to your door, and begin treatment with ongoing medical support.